These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17060395)

  • 1. Proteasomal regulation of cardiac hypertrophy: is demolition necessary for building?
    Dickhout JG; Austin RC
    Circulation; 2006 Oct; 114(17):1796-8. PubMed ID: 17060395
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy.
    Depre C; Wang Q; Yan L; Hedhli N; Peter P; Chen L; Hong C; Hittinger L; Ghaleh B; Sadoshima J; Vatner DE; Vatner SF; Madura K
    Circulation; 2006 Oct; 114(17):1821-8. PubMed ID: 17043166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibitors and cardiac cell growth.
    Hedhli N; Depre C
    Cardiovasc Res; 2010 Jan; 85(2):321-9. PubMed ID: 19578073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too much of a good thing is bad: proteasome inhibition induces stressed hearts to fail.
    Carrier L
    Cardiovasc Res; 2010 Dec; 88(3):389-90. PubMed ID: 20889761
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteasome inhibition and stress compromise the heart in chemotherapy.
    Appelman YE; Doevendans PA
    Cardiovasc Res; 2008 Sep; 79(4):547-8. PubMed ID: 18621801
    [No Abstract]   [Full Text] [Related]  

  • 6. Endoplasmic reticulum stress caused by left ventricular hypertrophy in rats: effects of telmisartan.
    Guan HS; Shangguan HJ; Shang Z; Yang L; Meng XM; Qiao SB
    Am J Med Sci; 2011 Oct; 342(4):318-23. PubMed ID: 21642821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-proteasome system in cardiomyopathies.
    Schlossarek S; Carrier L
    Curr Opin Cardiol; 2011 May; 26(3):190-5. PubMed ID: 21415726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibition in hypertrophied myocardium.
    Friehs I
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1373-4. PubMed ID: 18708439
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertrophy of the heart: a new therapeutic target?
    Frey N; Katus HA; Olson EN; Hill JA
    Circulation; 2004 Apr; 109(13):1580-9. PubMed ID: 15066961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac remodeling: UPS lost in transit.
    Razeghi P; Taegtmeyer H
    Circ Res; 2005 Nov; 97(10):964-6. PubMed ID: 16284188
    [No Abstract]   [Full Text] [Related]  

  • 12. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).
    Fujita E; Kouroku Y; Isoai A; Kumagai H; Misutani A; Matsuda C; Hayashi YK; Momoi T
    Hum Mol Genet; 2007 Mar; 16(6):618-29. PubMed ID: 17331981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake.
    Chen Q; Liu JB; Horak KM; Zheng H; Kumarapeli AR; Li J; Li F; Gerdes AM; Wawrousek EF; Wang X
    Circ Res; 2005 Nov; 97(10):1018-26. PubMed ID: 16210548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stressing the ubiquitin-proteasome system.
    Dantuma NP; Lindsten K
    Cardiovasc Res; 2010 Jan; 85(2):263-71. PubMed ID: 19633314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
    Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
    Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling.
    Wang X; Li F; Campbell SE; Gerdes AM
    J Mol Cell Cardiol; 1999 Feb; 31(2):319-31. PubMed ID: 10093045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and pathological role of the ubiquitin-proteasome system in the vascular smooth muscle cell.
    Demasi M; Laurindo FR
    Cardiovasc Res; 2012 Jul; 95(2):183-93. PubMed ID: 22451513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory roles of the ubiquitin-proteasome system in cardiomyocyte apoptosis.
    Sohns W; van Veen TA; van der Heyden MA
    Curr Mol Med; 2010 Feb; 10(1):1-13. PubMed ID: 20205676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.